The development of exceptional products starts with exceptional people
Founded in 2008, Antrum Biotech is co-owned by the University of Cape Town and the Industrial Development Corporation.
We are innovative, creative and work to achieve healthcare advances with social impact.
Our core scientific team are high profile professionals with over 25 years of experience in research and development. They are supported by a globally recognised Scientific Advisory Board committed to the development of superior quality products that improve patient well-being.
Our business is driven forward by seasoned business professionals represented on the Board of Directors.
Contact us
We are expanding our distributor network globally and welcome you to submit your company profile.
+27 74 198 8300
info@antrumbiotech.co
What drives us is the translation of research into a tangible product that has an impact on patients’ lives.
Our goal is to be a significant global contributor to healthcare innovation through translational research and development.
Our strategic areas of focus are to:
- Undertake discovery-related work to find new diagnostic biomarkers to be incorporated into rapid and point-of-care technologies
- Develop and market innovative point of care technologies that facilitate the rapid diagnosis of human TB and other pulmonary diseases.
- Distribute alternative novel and emerging technologies for the diagnosis and management of pulmonary and infectious diseases across Africa and other high disease burden countries.